Massimo Nardone أُعيد تغريده

RESEARCH ARTICLE: Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial @massnardone @DSchnekenB
ahajrnls.org/4rhIcAj

English



































